These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. [Tryptamine and serotonin metabolism in inflammatory diseases of the respiratory organs]. Tarlov EL; Kulinskii VI; Kononova LI Ter Arkh; 1978; 50(5):98-101. PubMed ID: 675524 [No Abstract] [Full Text] [Related]
44. Preoperative pulmonary evaluation of the dyspneic surgical candidate. Miller RD Surg Clin North Am; 1973 Aug; 53(4):805-11. PubMed ID: 4717251 [No Abstract] [Full Text] [Related]
45. [The detoxifying function of the pulmonary parenchyma in patients with acute infectious lung destruction]. Bel'skikh AN; Gurevich KIa; Tulupov AN; Kostiuchenko AL; Lishenko VV Anesteziol Reanimatol; 1994; (2):18-9. PubMed ID: 8059987 [TBL] [Abstract][Full Text] [Related]
46. [Potentialities of MRI in the differential diagnosis of peripheral lung cancer and inflammatory changes]. Gamova EV; Nudnov NV Vestn Rentgenol Radiol; 2006; (4):19-23. PubMed ID: 17633885 [TBL] [Abstract][Full Text] [Related]
47. [Evaluation of the results of postoperative treatment of various diseases of the heart and lungs by the electroretractography method]. Koblov LF Eksp Khir Anesteziol; 1967; 12(5):49-52. PubMed ID: 5620953 [No Abstract] [Full Text] [Related]
48. Indications for pneumonectomy. Pneumonectomy for benign disease. Conlan AA; Kopec SE Chest Surg Clin N Am; 1999 May; 9(2):311-26. PubMed ID: 10365265 [TBL] [Abstract][Full Text] [Related]
49. [Lung cancer complicated by inflammatory-suppurative process]. Zagorodskaia MM Vrach Delo; 1969 Aug; 8():40-2. PubMed ID: 5382483 [No Abstract] [Full Text] [Related]
51. [Change in tryptamine metabolism in vitamin B12 deficiency]. Gessler NN; Alekseeva NV; Bykhovskiĭ VIa Vopr Med Khim; 1994; 40(1):47-9. PubMed ID: 8122413 [TBL] [Abstract][Full Text] [Related]
52. [The effect of suppurative processes in the lungs on the function of other organs]. SHALAEV MI Sov Med; 1962 Nov; 26():12-7. PubMed ID: 13988393 [No Abstract] [Full Text] [Related]
53. [Surgical procedure in severe and complicated forms of suppurative lung diseases]. Bogdanov AV; Stonogin VD Grudn Khir; 1983; (3):64-8. PubMed ID: 6862279 [No Abstract] [Full Text] [Related]
54. Modulation of CYP1A2 enzyme activity by indoleamines: inhibition by serotonin and tryptamine. Agúndez JA; Gallardo L; Martínez C; Gervasini G; Benítez J Pharmacogenetics; 1998 Jun; 8(3):251-8. PubMed ID: 9682270 [TBL] [Abstract][Full Text] [Related]
55. [Study of the functional characteristics of thrombocytes of lung cancer patients with the "ERM-1" apparatus]. Koblov LF Vopr Onkol; 1969; 15(11):98-9. PubMed ID: 5368848 [No Abstract] [Full Text] [Related]
56. [Hyperbaric oxygenation in the treatment of patients with suppurative diseases of the lungs and pleura]. Bulynin VI; Koshelev PI; Alekseeva LN; Babkin VF; Merkulov AT Khirurgiia (Mosk); 1982 Sep; (9):56-9. PubMed ID: 7143979 [No Abstract] [Full Text] [Related]
57. [Effectiveness of conservative treatment of disseminated forms of chronic inflammatory-suppurative lung diseases]. Alekseenko AV Ter Arkh; 1980; 52(1):57-9. PubMed ID: 7368125 [No Abstract] [Full Text] [Related]
58. [Indications and contraindications of the use of therapeutic physical exercise in suppurative processes of the lung]. Dovgiallo GKh; Balykina RM Vopr Kurortol Fizioter Lech Fiz Kult; 1965; 30(2):165-70. PubMed ID: 5842914 [No Abstract] [Full Text] [Related]